Cite
Perspectives in the treatment of interstitial lung disease accompanied with anti‐melanoma differentiation‐associated gene 5‐positive dermatomyositis.
MLA
Tsuji, Hideaki, et al. “Perspectives in the Treatment of Interstitial Lung Disease Accompanied with Anti‐melanoma Differentiation‐associated Gene 5‐positive Dermatomyositis.” International Journal of Rheumatic Diseases, vol. 27, no. 5, May 2024, pp. 1–4. EBSCOhost, https://doi.org/10.1111/1756-185X.15201.
APA
Tsuji, H., Nakashima, R., & Mimori, T. (2024). Perspectives in the treatment of interstitial lung disease accompanied with anti‐melanoma differentiation‐associated gene 5‐positive dermatomyositis. International Journal of Rheumatic Diseases, 27(5), 1–4. https://doi.org/10.1111/1756-185X.15201
Chicago
Tsuji, Hideaki, Ran Nakashima, and Tsuneyo Mimori. 2024. “Perspectives in the Treatment of Interstitial Lung Disease Accompanied with Anti‐melanoma Differentiation‐associated Gene 5‐positive Dermatomyositis.” International Journal of Rheumatic Diseases 27 (5): 1–4. doi:10.1111/1756-185X.15201.